About

Orange Biotech, established in 2022 in Hong Kong, is a startup reagent company specializing in CRISPR technology and microfluidics. Our expert team from institutions like HKUST and Oxford is dedicated to developing innovative nucleic acid detection solutions for disease prevention and screening.

We offer integrated Point of Care Testing (POCT) products for home-based tests, focusing on disease confirmation, prevention, and post-treatment re-examination. Our mission includes bringing nucleic acid tests to the general public, akin to rapid antigen tests, with a focus on low cost, multiplexed diagnostics, and easy operation. Our goal is to make nucleic acid testing accessible and affordable for early disease detection and management, empowering individuals to prioritize their health.